MustGrow Biologics Corp. (TSXV:MGRO) has announced a significant milestone with the recent registration approval of its TerraSante product by the Florida Department of Agriculture and Consumer Services. TerraSante is an organic biofertility product derived from mustard plants, and this new certification adds to MustGrow’s existing Organic OMRI Listed certifications in several states including Arizona, Idaho, Oregon, and Washington.
The Florida registration and organic certification are pivotal elements of MustGrow's broader commercialization strategy for its BioAg products. The company emphasizes that these certifications not only validate TerraSante’s compliance with organic standards but also reinforce its commitment to sustainable agricultural practices. This step is expected to strengthen MustGrow’s position in the agricultural sector and support its growth in new markets.
Beyond the recent achievement in Florida, MustGrow has been proactive in securing similar approvals across various states, including Arizona, Idaho, California, Oregon, and Washington. The company is focused on continuing its efforts to obtain additional state-level registrations, reflecting its dedication to expanding its market reach and enhancing its operational capabilities.
MustGrow’s biofertility development programs are centered on improving soil health and microbiome balance, optimizing nutrient and water use efficiencies, and boosting plant yields. TerraSante, the company’s flagship organic biofertilizer, is formulated as a soluble mix containing plant proteins and carbohydrates. This innovative blend is designed to support soil microbes, enhance nutrient availability, and promote long-term soil health. By avoiding artificial additives or preservatives, TerraSante aims to improve crop nutrient uptake and overall plant vigor, ultimately contributing to increased yields.
This recent development underscores MustGrow's commitment to advancing sustainable and effective agricultural solutions. With its expanding portfolio of certifications and ongoing efforts in state-level registrations, the company is well-positioned to drive growth and make a significant impact in the biofertility market.